If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
It was reported that a female patient a cardiac ablation procedure with a thermocool® smart touch¿ electrophysiology catheter and suffered cardiac tamponade requiring unspecified intervention.During the paso module pace map phase, while using the bwi product, cardiac tamponade was confirmed.An unspecified intervention was provided.Patient stayed overnight.Patient had fully recovered from the event but still needs to be admitted for ventricular procedure.Physician¿s opinion regarding the cause of the adverse event is that it was related to patient¿s fibrotic tissue.Physician did not attribute the causality of the event to the bwi product.No ablation was done prior to the adverse event occurrence.No bwi product malfunctions nor error messages were reported.The force visualization features used included graph, dashboard, vector and visitag.Transseptal puncture was not done.Since this event is life threatening and required intervention to prevent permanent impairment of a body function or permanent damage to a body structure, it is to be considered serious and mdr-reportable.
|
On (b)(6) 2021, additional information was received indicating that the complaint device had been discarded.The product investigation was subsequently completed.Device investigation details: the device has been reported as discarded, therefore no product investigation can be performed, and the customer complaint cannot be confirmed.A manufacturing record evaluation was performed for the finished device 30444757m number, and no internal action related to the complaint was found during the review.This report is being submitted pursuant to the provisions of 21 cfr, part 4.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc.Or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|